http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9902186-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d4dec69358f077cebed0b510cdf3731
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71fd4aef0d0f39537efcf8c4e9a569d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a9f37cd86af3d4bc1d8e2f23b3c8a30
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-541
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H4-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01G7-00
filingDate 1998-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45854e417380cbb87d3d21c3dccf5b59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70ecad5258aa906e41a3e6f8abf6f2e9
publicationDate 1999-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9902186-A3
titleOfInvention Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant
abstract Adjuvants for administration, particularly for mucosal administration, of an antigen, are described, as well as compositions comprising the described adjuvant in combination with an antigen and a physiologically acceptable vehicle. Methods of eliciting and enhancing an immune response utilizing the adjuvant compositions of the invention are also described. The adjuvant comprises mono- or diglycerides containing at least one water soluble polymer, e.g. poly oxyethylene (PEG2-30). The antigen can be bound to the adjuvant. The adjuvant may be used in the treatment of plants as well.
priorityDate 1997-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9624374-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0275709-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4681900-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5633226-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4420484-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-822718-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9622109-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0781559-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9218147-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5561062-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9408604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4567161-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9417827-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9321293-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4349540-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4911928-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0324455-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420229795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13296868

Total number of triples: 45.